Brief: RaQualia Pharma gets FDA approval
18/05/2016 08:38
May 18 (Reuters) - RaQualia Pharma Inc 4579.T :
* Says the company received approval for Entyce from the
U.S. Food and Drug Administration (FDA) in U.S. on May 17
* Says Entyce is for the treatment of dogs' anorexia
Source text in Japanese:https://goo.gl/tZUCGI
Further company coverage: 4579.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))
Keywords: RAQUALIA PHARMA/BRIEF